Search results
-
Key Performance Indicators
Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.
-
Danuta Gray, Chair's Letter 2024
The Board and shareholders are aligned that the Company’s priorities should be execution and operational delivery to grow earnings and improve returns on invested capital.
-
Steve Foots, Group Chief Executive Letter
We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.
-
Consumer Care business review
Discover how Consumer Care is reinvigorating Beauty and enabling continued growth in Fragrances & Flavours. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Annual Report
Find our 2023 Annual Report here
-
Sustainability Impact Report
Find our 2023 Sustainability Impact Report here
-
Our business model
Our business model is designed to create long-term, sustainable value.
-
Investor overview
Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.
-
Share price
Detailed share charts.
-
Our centenary
2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.
-
Shareholder centre
Useful information for Croda Shareholders.
-
Shareholder information
Keep up to date with shareholder and investor information.
-
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by biotechnology.
-
Our Purpose
At Croda, our purpose is to use Smart science to improve lives™ through a values-led culture that shapes our work and partnerships. Our knowledge, passion, and entrepreneurial spirit drive the creation of specialty ingredients trusted by industries and consumers worldwide.
-
Types of careers at Croda
Learn more about the types of careers available at Croda.
-
Working with Croda
Learn more about working with Croda.
-
Careers
Here at Croda, our people and operations are what make us who we are, we have people across the world, operating in 37 different countries.
-
A day in the life of our IT team
Welcome to a behind-the-scenes look at the world of Information Technology (IT) at Croda.
-
Regulatory news
Our most recent announcements to the stock exchange.
-
About us
We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.
-
EMEA
Our global headquarters are based in Yorkshire in the UK. We also have a number of offices and manufacturing sites spread across the region.
-
USA
Croda Inc is the North American headquarters for Croda, with over 800 employees, working in a variety of roles in manufacturing, sales, marketing and research and development.
-
Latin America
In Latin America, we have a manufacturing site in Campinas, Brazil and six other sales offices within the region.
-
Where we operate
Every day our global team, across 37 countries, work together to inspire our customers.
-
Focusing on D&I in Asia
Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.
-
Investing in mRNA and gene therapy
As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology.
-
ASD Kaleka Mosaik Initiative Impact Fund
We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.
-
Sustainable ways of working in R&D
We are focused on aligning the work of our global R&D teams with the United Nations Sustainable Development Goals (SDGs).
-
Most Admired Company in the British Chemical Sector for the Fourth Year Running
Voted Britain’s Most Admired Chemicals Company for the fourth year running, as well as being named Britain’s fifth Most Admired Company overall.
-
Acquisitions
Commercialising and increasing our access to new ideas and technologies.
-
Validation of our 1.5°C Science Based Targets
We have become one of only three major chemical companies in the world to have our 1.5°C Science Based Targets validated.
-
Crodarom expands its Chanac France site
Crodarom, producer of botanical extracts, is launching its first investment program to expands its Chanac production site location in France.
-
Task force for more sustainable polymers
Helping create a more sustainable future as founder members of the Polymers in Liquid Formulations task force.
-
Croda calls on the UK Government to deliver a clean and just recovery plan
We are proud to be one of 200 UK businesses that have called on the UK Government to deliver a ‘clean and just’ recovery plan
-
Alganelle Sederma partnership
A partnership to create a cosmetic active ingredient of the future
-
Croda becomes founding member of sustainability Business Transformation Group
We are proud to be a founding member of the CISL Business Transformation Group.
-
Croda announces registered name for its innovative non-animal keratin for hair repair.
14 July 2025: Croda International Plc today announce registered name for its innovative non-animal keratin for hair repair.
-
Croda joins the Together for Sustainability initiative
Croda becomes the 30th member of TfS
-
CrodaTherm helps COVID19 nurses in The Netherlands
CrodaTherm™ helps reduce heat strain experienced by COVID-19 nurses in The Netherlands
-
Croda supports Kayapo indigenous people during COVID19
We are continuing to support local communities during the COVID-19 pandemic by providing soap bars to indigenous communities in Brazil
-
Celebrating a century of Croda
Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.
-
Driving innovation in the Agriculture market
Through Croda’s acquisition of the Incotec Seed Enhancement business in 2015 and the Plant Impact Biostimulants business in 2018, we are well placed to address some of the challenges in the adoption of biologics.
-
CroBioticTM 100
Surveys indicate that malodour of garments is one of the biggest reasons that consumers choose to wash them.
-
Customer award for carbon reduction
We’ve been working in partnership with Syngenta to deliver innovative and sustainable ingredients in a way that meets their commercial and sustainability goals.
-
Sustainability without compromise ChromaPur
Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling cosmetics brands contain these microplastics.
-
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
-
Croda and Anome Collaboration Promises a Positive Difference in Beauty Effects
We are very proud to announce a new collaborative partnership with Anomera, an award-winning innovator in green chemistry, materials science and sustainable manufacturing.
-
Biodegradable fragrance encapsulation
Fragrance encapsulation involves advanced delivery systems that allow the timed release of fragrances, critical in various applications such as laundry, fabric softeners and deodorants.
-
Croda donates solar panel modules to non-profit organisations
We have donated 1,000 SunPower solar panels to three non-profit organizations for use in low-income housing and crop generation.
-
Croda supports Pfizer-BioNTech COVID-19 vaccine
Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.